Wang Y, Lilienfeldt N, Hekimi S
Physiol Rev. 2024; 104(4):1533-1610.
PMID: 38722242
PMC: 11495197.
DOI: 10.1152/physrev.00040.2023.
Staiano C, Garcia-Corzo L, Mantle D, Turton N, Millichap L, Brea-Calvo G
Antioxidants (Basel). 2023; 12(7).
PMID: 37508007
PMC: 10375973.
DOI: 10.3390/antiox12071469.
Wang S, Jain A, Novales N, Nashner A, Tran F, Clarke C
Antioxidants (Basel). 2022; 11(12).
PMID: 36552517
PMC: 9774615.
DOI: 10.3390/antiox11122308.
Nam D, Park S, Lee S, Suh M, Park M, Song J
Biomed Res Int. 2022; 2022:5250254.
PMID: 36124066
PMC: 9482153.
DOI: 10.1155/2022/5250254.
Wang N, Zheng Y, Zhang L, Tian X, Fang Y, Qi M
Front Genet. 2022; 12:811833.
PMID: 35111204
PMC: 8802230.
DOI: 10.3389/fgene.2021.811833.
Cellular Models for Primary CoQ Deficiency Pathogenesis Study.
Santos-Ocana C, Cascajo M, Alcazar-Fabra M, Staiano C, Lopez-Lluch G, Brea-Calvo G
Int J Mol Sci. 2021; 22(19).
PMID: 34638552
PMC: 8508219.
DOI: 10.3390/ijms221910211.
Primary coenzyme Q10 nephropathy, a potentially treatable form of steroid-resistant nephrotic syndrome.
Tan W, Airik R
Pediatr Nephrol. 2021; 36(11):3515-3527.
PMID: 33479824
PMC: 8295399.
DOI: 10.1007/s00467-020-04914-8.
mutation associated isolated nephropathy in two siblings from a Chinese pedigree.
Li M, Yue Z, Lin H, Wang H, Chen H, Sun L
Ren Fail. 2021; 43(1):97-101.
PMID: 33397173
PMC: 7801106.
DOI: 10.1080/0886022X.2020.1864402.
Compound heterozygous inheritance of two novel COQ2 variants results in familial coenzyme Q deficiency.
Abdelhakim A, Dharmadhikari A, Ragi S, Lima de Carvalho Jr J, Xu C, Thomas A
Orphanet J Rare Dis. 2020; 15(1):320.
PMID: 33187544
PMC: 7662744.
DOI: 10.1186/s13023-020-01600-8.
Current understandings in treating children with steroid-resistant nephrotic syndrome.
Lee J, Kronbichler A, Shin J, Oh J
Pediatr Nephrol. 2020; 36(4):747-761.
PMID: 32086590
PMC: 7910243.
DOI: 10.1007/s00467-020-04476-9.
β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in mice.
Hidalgo-Gutierrez A, Barriocanal-Casado E, Bakkali M, Diaz-Casado M, Sanchez-Maldonado L, Romero M
EMBO Mol Med. 2018; 11(1).
PMID: 30482867
PMC: 6328940.
DOI: 10.15252/emmm.201809466.
CoQ supplementation rescues nephrotic syndrome through normalization of HS oxidation pathway.
Kleiner G, Barca E, Ziosi M, Emmanuele V, Xu Y, Hidalgo-Gutierrez A
Biochim Biophys Acta Mol Basis Dis. 2018; 1864(11):3708-3722.
PMID: 30251690
PMC: 6181133.
DOI: 10.1016/j.bbadis.2018.09.002.
CoQ10-related sustained remission of proteinuria in a child with COQ6 glomerulopathy-a case report.
Stanczyk M, Balasz-Chmielewska I, Lipska-Zietkiewicz B, Tkaczyk M
Pediatr Nephrol. 2018; 33(12):2383-2387.
PMID: 30232548
PMC: 6208703.
DOI: 10.1007/s00467-018-4083-3.
Coenzyme Q deficiencies: pathways in yeast and humans.
Awad A, Bradley M, Fernandez-Del-Rio L, Nag A, Tsui H, Clarke C
Essays Biochem. 2018; 62(3):361-376.
PMID: 29980630
PMC: 6056717.
DOI: 10.1042/EBC20170106.
Coenzyme Q Supplementation in Aging and Disease.
Hernandez-Camacho J, Bernier M, Lopez-Lluch G, Navas P
Front Physiol. 2018; 9:44.
PMID: 29459830
PMC: 5807419.
DOI: 10.3389/fphys.2018.00044.
Mutations in COQ8B (ADCK4) found in patients with steroid-resistant nephrotic syndrome alter COQ8B function.
Vazquez Fonseca L, Doimo M, Calderan C, Desbats M, Acosta M, Cerqua C
Hum Mutat. 2017; 39(3):406-414.
PMID: 29194833
PMC: 5838795.
DOI: 10.1002/humu.23376.
